Surpass Medical Acquired by Stryker Corporation
TM Capital advised Surpass Medical, Ltd. in its sale to Stryker Corporation (NYSE:SYK) for $135 million in cash and future consideration
Immucor Board of Directors Re-Elected
TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor’s directors were successfully re-elected
Holland Capital’s Quantib has been Acquired by RadNet
TM Capital served as exclusive financial advisor to Quantib B.V., a portfolio company of Holland Capital, in connection with its sale to RadNet, Inc.